Balasa, Jovine K.
HRN: 05-19-56 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/08/2026
AMPICILLIN 1GM (VIAL)
05/08/2026
05/15/2026
IV
2G
Q6
PROM X 17 HRS
Checking Initial Appropriateness
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines